Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 17, 2021, titled "Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited receives USFDA Final Approval for Mupirocin Cream USP, 2%".